Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep178 | Endocrine tumours and neoplasia | ECE2017

Dysregulation of the components of the splicing machinery in neuroendocrine tumors and its association with malignancy and aggressiveness

Pedraza-Arevalo Sergio , Alors-Perez Emilia , Herrera-Martinez Aura D. , del Rio-Moreno Mercedes , Sanchez-Sanchez Rafael , Ortega-Salas Rosa , Serrano-Blanch Raquel , Galvez-Moreno Maria A. , Gahete Manuel D. , Luque Raul M. , Castano Justo P.

Dysregulation of the splicing machinery is emerging as a novel cancer hallmark due to its association with multiple dysfunctions in tumor cells. An inappropriate function of the components of this machinery (spliceosome) could be primarily linked with the generation of tumor-associated aberrant splicing variants. In line with this, we have previously reported that overexpression of aberrantly spliced variants of somatostatin receptor 5 (sst5TMD4) and ghrelin (In1-ghrelin) is d...

ea0049ep698 | Obesity | ECE2017

Associations between the dysregulation of splicing machinery components and the development of hepatic steatosis in obese women

del Rio-Moreno Mercedes , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M , Gahete Manuel D

: Hepatic steatosis is a common obesity-associated pathology characterized by the accumulation of fat within the liver, which can progress to liver fibrosis, cirrhosis and ultimately lead to hepatocellular carcinoma. Remarkably, obesity and cancer course with a profound dysregulation of the genetic expression patterns and, particularly, with the aberrant expression of splicing variants that could contribute to the aggressiveness and comorbidities of these pathologies. Since th...

ea0049ep790 | Endocrine tumours and neoplasia | ECE2017

Altered expression of the components of the splicing machinery is associated to increased malignancy and expression of aberrant splicing variants in prostate cancer

Jimenez-Vacas Juan M , Gahete Manuel D , Pedraza-Arevalo Sergio , del Rio-Moreno Mercedes , Hormaechea-Agulla Daniel , Gomez-Gomez Enrique , Carrasco-Valiente Julia , del Mar Moreno Maria , Jose Requena-Tapia Maria , Castano Justo P , Luque Raul M

: Prostate cancer (PCa) is the most common cancer among men in developed countries. Unfortunately, the heterogeneity of this malignancy hinders the finding of new biomarkers and therapeutic tools. A potential factor contributing to PCa is alternative splicing, which can generate the appearance of oncogenic variants involved in PCa aggressiveness. Thus, we hypothesized that the alteration of the splicing machinery (spliceosome components and splicing factors (SFs)) could be ass...

ea0041oc3.1 | Diabetes prediction & complications | ECE2016

Identification of a spliceosome-associated fingerprint with potential to predict development of type 2 diabetes in high-risk patients

Luque Raul M. , Gahete Manuel D. , Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Camargo Antonio , Delgado-Lista Javier , Gracia-Navarro Francisco , Perez-Jimenez Francisco , Lopez-Miranda Jose , Castano Justo P.

Prevalence of metabolic syndrome (MetS) and type-2 Diabetes (T2D) is growing dramatically worldwide. Loss of phenotypic flexibility, i.e. the difficulty to cope with different stressors to maintain metabolic homeostasis, contributes critically to the development of MetS/T2DM. Thus, it is essential to identify the key modifiers of phenotypic plasticity that define an individualÂ’s susceptibility to develop T2DM. In this scenario, emerging evidence indicates that, under adve...

ea0041oc9.4 | Endocrine Tumours | ECE2016

The truncated somatostatin receptor sst5TMD4 is overexpressed in prostate cancer, where it increases aggressiveness features by regulating key tumor suppressors and oncogenes.

Hormaechea-Agulla Daniel , Manuel Jimenez-Vacas Juan , Ibanez-Costa Alejandro , Gomez-Gomez Enrique , Carrasco-Valiente Julia , Valero Rosa Jose , Moreno Maria M , Culler Michael D , Gahete Manuel D , Jose Requena Maria , Castano Justo P , Luque Raul M

Somatostatin is a pleiotropic neuropeptide that governs multiple biological targets, including tumor cell function, through a family of G protein-coupled receptors with 7-transmembrane domains (TMD), named sst1-5. However, we recently discovered sst5TMD4, an aberrantly spliced, truncated (only 4-TMDs) sst5-variant displaying unique molecular/functional features. sst5TM4 is overexpressed in various endocrine-related tumors exacerbating their malignant characteristics. Here, we ...

ea0041gp131 | Obesity | ECE2016

The liver of obese patients with hepatic steatosis exhibits a severe dysregulation of key splicing machinery components as compared to obese patients without hepatic steatosis

Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Gahete Manuel D , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M

Obesity, a disease that is growing at epidemic proportions worldwide, is caused by a combination of genetic and lifestyle factors. One of the most common pathologies associated with obesity is hepatic steatosis, an accumulation of fat within the liver that can progress to liver fibrosis, cirrhosis, and ultimately lead to hepatocellular carcinoma. There is emerging evidence that alternative mRNA splicing, the key mechanism providing transcript and protein diversity, is dysregul...

ea0035p788 | Obesity | ECE2014

Dietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: Putative implications in the postprandial inflammatory response

Gahete Manuel D. , Luque Raul M. , Yubero-Serrano Elena M. , Cruz-Teno Cristina , Ibanez-Costa Alejandro , Delgado-Lista Javier , Gracia-Navarro Francisco , Perez-Jimenez Francisco , Castano Justo P. , Lopez-Miranda Jose

Dietary fat influences systemic inflammatory status, which, in turn, determines the progression of age-associated diseases. Peripheral blood mononuclear cells (PBMCs) comprise a subset of white blood cells placed at the crossroad between diet and inflammation, in that they play a key role in the immune/inflammatory system and their gene expression pattern is influenced by diet. Since the somatostatin (SST), cortistatin (CORT) and ghrelin systems have been shown to modulate the...

ea0070aep539 | Endocrine-related Cancer | ECE2020

Involvement of the splicing machinery in the antitumoral actions of metformin in prostate cancer

Montero-Hidalgo Antonio J. , Jiménez-Vacas Juan M. , Herrero-Aguayo Vicente , Sarmento-Cabral André , López Miguel , Castaño Justo P , Gahete Manuel D , Luque Raúl M

Metformin has recently emerged as a potential therapeutic tool for different tumour pathologies, including prostate cancer (PCa)1, one of the leading causes of cancer-deaths in men worldwide. However, the molecular mechanisms underlying the antitumor effects of metformin in PCa are not fully elucidated. In this context, previous reports have suggested a relationship between metformin and the process of alternative splicing in some cell-types. Nevertheless, the poten...

ea0014s5.4 | Novel bioactive peptides – lessons from animals | ECE2007

Somatostatin, cortistatin and their new and old receptors: from comparative to translational endocrinology

Castaño Justo P. , Durán-Prado Mario , Vázquez-Martínez Rafael , Martínez-Fuentes Antonio J. , Gahete Manuel D. , Luque Raul M. , Malagón Maria M.

omatostatin, originally isolated from ovine hypothalami in 1973, and cortistatin, identified a decade ago in amphibians and then in human and rodents, are two highly related peptides thought to derive from a common ancestor gene. Owing to their high structural homology, both peptides bind with similar affinity to the five so-called somatostatin receptors (sst1-sst5), and exert virtually undistinguishable effects on several physiological targets, including inhibition of endocri...

ea0056gp48 | Adrenal medulla and NETs | ECE2018

In vitro studies reveal a potential therapeutic role of the combination of biguanides and statins for the treatment of prostate cancer

Herrero-Aguayo Vicente , Jimenez-Vacas Juan M , Gomez-Gomez Enrique , Leon-Gonzalez Antonio J , Saez-Martinez Prudencio , Requena-Tapia Maria J , Gahete Manuel D , Castano Justo P , Luque Raul M

Prostate cancer (PCa) is the most common tumor pathology in men worldwide. The medical treatments currently used as first-line therapy after surgery are anti-androgens like abiraterone or enzalutamide, which, unfortunately, fail to stop the disease in a high percentage of cases, resulting in progression towards aggressive castration-resistant PCa. Therefore, new therapeutic tools to manage PCa are urgently needed. Biguanides and statins, two types of drugs commonly used in met...